Morphine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Morphine Sulfate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 3, 2017. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-6039-01
- Dosage Form
- Injection
- Presentation
- Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)
- Initial Posting
- Nov 3, 2017
Reason
Demand increase for the drug